Lanza R P, Kühtreiber W M, Ecker D, Staruk J E, Chick W L
BioHybrid Technologies, Inc., Shrewsbury, Massachusetts 01545, USA.
Transplantation. 1995 May 27;59(10):1377-84. doi: 10.1097/00007890-199505270-00003.
Uncoated spherical hydrogel microspheres (calcium alginate, nominal M(r) exclusion of > 600 kD) 800-900 microns in diameter were employed to prevent immune rejection of discordant islet xenografts isolated from pigs and cows. The islets were immobilized in the microspheres and injected into the peritoneum of 14 nonimmunosuppressed streptozotocin (STZ)-induced diabetic C57BL/6J mice. Four recipients received islet grafts from bovine calves, and 10 received islet grafts from pigs. In the control group of 15 diabetic mice implanted with nonencapsulated islets, 6 received i.p. porcine islets and 5 received i.p. bovine islets, whereas remaining 4 received porcine islets under the kidney capsule. Plasma glucose concentrations in recipients of the alginate-encapsulated islets promptly dropped from a preimplantation value of 498 +/- 47 (mean +/- SEM) to 142 +/- 6 (bovine) and 178 +/- 7 mg/dl (porcine) during the first wk. All the animals sustained these levels for at least 1 mo. Two mice implanted with bovine islets subsequently reverted to diabetes (plasma glucose > 250 mg/dl) at 43 days postimplantation. The remaining grafts maintained function for > 10 wk. In contrast, nonencapsulated islets failed to function, or sustained euglycemia for < 4 days. Mice receiving encapsulated islets showed a 23-38% gain in body weight during the first mo after implantation, compared with < 1% (P < 0.002) and 32% (P = 0.84) for the untreated diabetic (n = 6) and normal control (n = 6) groups. Immunohistochemical staining of long-term grafts (> 10 wk) revealed viable islets, with well-granulated alpha, beta, and delta cells; the external surfaces of the microreactors were free of fibrotic overgrowth and exhibited only occasional host cell adherence. Uptake studies with IgG and thyroglobulin (M(r) of 669 kD) suggest that the microreactors were permeable to molecules with a molecular weight of up to > 600 kD (including the various proteins of the complement system, M(r) of 24-570 kD). Spheres implanted in the peritoneum after only 1 wk stained positive for both IgG and for the C3 component of complement. These findings suggest that prolonged survival of discordant xenografts of porcine and bovine islets in the STZ diabetic mouse model can be achieved with uncoated alginate microspheres that are permeable to IgG and complement. The question of whether similar results can be achieved with uncoated alginate microspheres in higher animals remains to be fully determined.
使用直径为800 - 900微米的未包被球形水凝胶微球(海藻酸钙,标称排阻分子量> 600 kD)来防止从猪和牛分离的不匹配胰岛异种移植物的免疫排斥。将胰岛固定在微球中,并注射到14只未进行免疫抑制的链脲佐菌素(STZ)诱导的糖尿病C57BL/6J小鼠的腹腔内。4只受体接受来自牛犊的胰岛移植,10只接受来自猪的胰岛移植。在植入未包被胰岛的15只糖尿病小鼠对照组中,6只接受腹腔内猪胰岛移植,5只接受腹腔内牛胰岛移植,其余4只接受肾包膜下猪胰岛移植。在第一周内,海藻酸包被胰岛受体的血浆葡萄糖浓度迅速从植入前的498±47(平均值±标准误)降至142±6(牛)和178±7 mg/dl(猪)。所有动物至少维持这些水平1个月。两只植入牛胰岛的小鼠在植入后43天随后恢复糖尿病(血浆葡萄糖> 250 mg/dl)。其余移植物维持功能> 10周。相比之下,未包被的胰岛未能发挥功能,或维持血糖正常< 4天。接受包被胰岛的小鼠在植入后的第一个月体重增加了23 - 38%,而未治疗的糖尿病组(n = 6)和正常对照组(n = 6)分别为< 1%(P < 0.002)和32%(P = 0.84)。长期移植物(> 10周)的免疫组织化学染色显示有存活的胰岛,α、β和δ细胞颗粒良好;微反应器的外表面没有纤维化过度生长,仅偶尔有宿主细胞粘附。用IgG和甲状腺球蛋白(分子量669 kD)进行的摄取研究表明,微反应器对分子量高达> 600 kD的分子(包括补体系统的各种蛋白质,分子量24 - 570 kD)具有通透性。仅1周后植入腹腔的微球对IgG和补体C3成分均呈阳性染色。这些发现表明,使用对IgG和补体具有通透性的未包被海藻酸微球,可以在STZ糖尿病小鼠模型中实现猪和牛胰岛不匹配异种移植物的长期存活。在高等动物中使用未包被海藻酸微球是否能获得类似结果的问题仍有待充分确定。